|
Allvivo
Vascular, Inc. (AVI) is a company founded in December of 2003
as a spin-off entity of allvivo, Inc. (allvivo). AVI holds an
exclusive worldwide license for allvivo, Inc.'s biomimetic
surface technologies in the cardiovascular field of use. Given
allvivo's broad technology platform and opportunities to
develop the EGAP coating for other markets, the spin-off
strategy has provided strategic focus and dedicated funding
for introducing allvivo's technology to the coronary market.
AVI maintains a 5,000 sq.ft. research and administrative
facility in Lake Forest, CA.
allvivo,
Inc. was formed in December of 1999 in Birmingham, AL to
design tools for proteomics and cellomics research based on
proprietary coating technologies developed originally at the
University of Utah's Center for Biopolymers and Interfaces. In
the spring of 2002, the company relocated to Southern
California and shifted its strategic focus to address clinical
applications, i.e. drug device combination products.
For more information, please
contact:
Jennifer Neff, Ph.D.
Chief Technology Officer
Email:
neff@allvivo.com
|
